| ORIGINAL ARTICLE |
|
| Year : 2022 | Volume
: 19
| Issue : 4 | Page : 589-594 |
|
|
Incidence of acute kidney injury in hospitalized COVID-19 patients
Yasamine Abdul Hussein Abdul Waheed1, Haider Mehdi Mueen Al-Shireefy2
1 Department of Family and Community Medicine, College of Medicine, University of Babylon, Hilla, Babil, Iraq
2 Department of Medicine, College of Medicine, University of Babylon, Hilla, Babil, Iraq
Correspondence Address:
Yasamine Abdul Hussein Abdul Waheed
Department of Family and Community Medicine, College of Medicine, University of Babylon, Hilla, Babil
Iraq
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/MJBL.MJBL_143_22
|
|
|
Background: Acute kidney injury (AKI) is common among patients hospitalized with COVID-19 and associated with worse prognosis. Objective: We aim to assess the incidence of AKI in hospitalized COVID-19 patients. Materials and Methods: This is a retrospective cross-sectional study conducted at Merjan Teaching Hospital from May 1 to October 1, 2021. It involved a review of data of 174 hospitalized polymerase chain reaction–confirmed COVID-19 patients from hospital health records. Results: In our hospitalized COVID-19 patients, AKI was found in 14 patients forming 8.05% of the total hospitalized patients. The age of participants with AKI was 62.64 ± 19.08 years; male patients formed the larger proportion (53.45%). More than one-third of the patients (36.21%) had a history of hypertension, and more than one-fifth of the patients had a history of diabetes mellitus (22.99%). History of ischemic heart disease was present in 4.60%, heart failure in 0.57%, asthma in 3.45%, chronic obstructive pulmonary disease in 1.15%, cerebrovascular accidents in 1.75%, and lung fibrosis in 1.15%. Patients with AKI had a significantly higher level of blood urea (22.44 ± 11.74); the level of serum creatinine was also significantly higher among patients with AKI (267.57 ± 87.27); significant relationship was observed between the outcome of the patient and the incidence of AKI. Conclusions: The current study showed a higher risk of mortality and morbidity in COVID-19 patients with AKI. Identifying high-risk groups and earlier diagnosis of AKI in COVID-19 patients can improve results in patients and decrease mortality. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
